Shepherd Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Buy
4,300
+4
+0.1% +$1.43K 0.14% 91
2025
Q4
$1.41M Buy
4,296
+2,897
+207% +$919K 0.13% 100
2025
Q3
$395K Buy
1,399
+7
+0.5% +$2.03K 0.04% 176
2025
Q2
$389K Sell
1,392
-144
-9% -$40.8K 0.04% 173
2025
Q1
$479K Buy
1,536
+1
+0.1% +$295 0.06% 156
2024
Q4
$400K Sell
1,535
-8
-0.5% -$2.37K 0.05% 158
2024
Q3
$497K Buy
1,543
+161
+12% +$52.7K 0.06% 144
2024
Q2
$432K Sell
1,382
-65
-4% -$19.1K 0.06% 155
2024
Q1
$411K Sell
1,447
-43
-3% -$12.6K 0.05% 164
2023
Q4
$429K Sell
1,490
-126
-8% -$34.3K 0.06% 151
2023
Q3
$434K Sell
1,616
-9
-0.6% -$2.25K 0.07% 141
2023
Q2
$361K Sell
1,625
-15
-0.9% -$3.48K 0.06% 148
2023
Q1
$396K Buy
1,640
+285
+21% +$70K 0.07% 140
2022
Q4
$356K Buy
1,355
+87
+7% +$23.3K 0.06% 136
2022
Q3
$286K Buy
1,268
+109
+9% +$26.4K 0.06% 139
2022
Q2
$282K Buy
1,159
+331
+40% +$81.1K 0.05% 140
2022
Q1
$200K Buy
+828
New +$190K 0.04% 156

Other funds holding AMGN

Shepherd Financial Partners's AMGN Position: Q1 2026 in Review

Shepherd Financial Partners increased its Amgen (AMGN) stake by 0.09% in Q1 2026, buying an estimated $1.43K and bringing the position to 4,300 shares worth $1.51M. The position accounts for 0.14% of the portfolio, ranked #91.

Shepherd Financial Partners first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Shepherd Financial Partners held 4,300 shares of Amgen worth $1.51M as of Q1 2026.
  • Shepherd Financial Partners bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
  • Amgen made up 0.14% of Shepherd Financial Partners's portfolio in Q1 2026, its #91 holding.
  • Shepherd Financial Partners first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Shepherd Financial Partners's 13F filing for Q1 2026, filed 11 May 2026.